This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1998 Aug 8;352(9126):489-90.

doi: 10.1016/s0140-6736(05)79229-1.

Insulin-like growth factor-I and risk of breast cancer

C Florkowski, J Livesey, E Espiner

PMID: 9708784
DOI: 10.1016/s0140-6736(05)79229-1

Comment

Insulin-like growth factor-I and risk of breast cancer

C Florkowski et al. Lancet. 1998.

. 1998 Aug 8;352(9126):489-90.

doi: 10.1016/s0140-6736(05)79229-1.

Authors

C Florkowski, J Livesey, E Espiner

PMID: 9708784
DOI: 10.1016/s0140-6736(05)79229-1

No abstract available

PubMed Disclaimer

Comment on

Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.
Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M. Hankinson SE, et al. Lancet. 1998 May 9;351(9113):1393-6. doi: 10.1016/S0140-6736(97)10384-1. Lancet. 1998. PMID: 9593409

Similar articles

[Growth hormone in children and adolescents: facts and fiction].
Burckhardt MA, Zumsteg U. Burckhardt MA, et al. Praxis (Bern 1994). 2013 Jun 19;102(13):777-84. doi: 10.1024/1661-8157/a001338. Praxis (Bern 1994). 2013. PMID: 23773936 Review. German.
Experience with insulin-like growth factor I (IGF-I) treatment of growth hormone insensitivity syndrome (GHIS).
Ranke MB, Wollmann HA, Savage MO. Ranke MB, et al. J Pediatr Endocrinol Metab. 1999 Apr;12 Suppl 1:259-66. J Pediatr Endocrinol Metab. 1999. PMID: 10698590 Review. No abstract available.
Off-label use of recombinant igf-I to promote growth: is it appropriate?
Rosenbloom AL, Rivkees SA. Rosenbloom AL, et al. J Clin Endocrinol Metab. 2010 Feb;95(2):505-8. doi: 10.1210/jc.2009-2450. J Clin Endocrinol Metab. 2010. PMID: 20133470 No abstract available.
Therapy of growth disorders.
Ali O, Wyatt D. Ali O, et al. Curr Opin Endocrinol Diabetes Obes. 2011 Feb;18(1):3-8. doi: 10.1097/MED.0b013e328341f873. Curr Opin Endocrinol Diabetes Obes. 2011. PMID: 21150587 Review.
Safety of growth hormone treatment of children with idiopathic short stature: the US experience.
Allen DB. Allen DB. Horm Res Paediatr. 2011;76 Suppl 3:45-7. doi: 10.1159/000330159. Epub 2011 Sep 7. Horm Res Paediatr. 2011. PMID: 21912165

See all similar articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information